Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Aurobindo Pharma Ltd. (ARBN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,264.75 +13.45    +1.07%
07/06 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE406A01037 
S/N:  AUROPHARMA
  • Volume: 1,879,910
  • Bid/Ask: 1,264.75 / 1,265.00
  • Day's Range: 1,251.50 - 1,292.10
Aurobindo Pharma 1,264.75 +13.45 +1.07%

ARBN Ratios

 
Assess the performance of Aurobindo Pharma (ARBN). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Aurobindo Pharma Ltd.'s latest financial reports. Compare the performance metrics of Aurobindo Pharma (ARBN) against the industry averages.
Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 23.36 17.47
Price to Sales TTM 2.56 7.29
Price to Cash Flow MRQ 30.44 2.12
Price to Free Cash Flow TTM -214.3 64.07
Price to Book MRQ 2.48 7.35
Price to Tangible Book MRQ 2.88 7.41
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 56.54% 64
Gross Margin 5YA 55.55% 63.15
Operating margin TTM 14.9% 16.07
Operating margin 5YA 14.93% 19.48
Pretax margin TTM 15.1% 16.6
Pretax margin 5YA 17.18% 19.8
Net Profit margin TTM 10.94% 12
Net Profit margin 5YA 12.77% 12.36
   
Revenue/Share TTM 494.96 451.88
Basic EPS ANN 54.16 63.16
Diluted EPS ANN 54.16 63.1
Book Value/Share MRQ 509.32 397.67
Tangible Book Value/Share MRQ 439.76 332.29
Cash/Share MRQ 107.15 80.43
Cash Flow/Share TTM 41.55 82.86
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 11.2% 15.82
Return on Equity 5YA 16.14% 49.57
Return on Assets TTM 7.46% 2.27
Return on Assets 5YA 9.64% 9.84
Return on Investment TTM 9.44% 14.59
Return on Investment 5YA 10.87% 13.05
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 79.51% -35.06
EPS(TTM) vs TTM 1 Yr. Ago TTM 64.64% 58.24
5 Year EPS Growth 5YA 6.06% 15.98
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 17.1% 10.65
Sales (TTM) vs TTM 1 Yr. Ago TTM 16.68% 222.09
5 Year Sales Growth 5YA 8.19% 12.3
5 Year Capital Spending Growth 5YA 14.29% 3.39
   
Quick Ratio MRQ 0.91 1.91
Current Ratio MRQ 1.98 0.43
LT Debt to Equity MRQ 7.15% 6.1
Total Debt to Equity MRQ 22.28% 15.87
Efficiency    
Asset Turnover TTM 0.68 0.07
Inventory Turnover TTM 1.38 3.41
Revenue/Employee TTM - 10.40M
Net Income/Employee TTM - 1.35M
Receivable Turnover TTM - 0.29
   
Dividend Yield ANN 0.41% 0.95
Dividend Yield 5 Year Avg. 5YA 0.82% 0.84
Dividend Growth Rate ANN -40% 8.43
Payout Ratio TTM 8.31% 2.57
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARBN Comments

Write your thoughts about Aurobindo Pharma Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
invest market
INVEST2MARKETS May 01, 2024 11:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update AUROPHARMA Revised Stop Loss 1140 from 1100 (Cost2Cost)
invest market
INVEST2MARKETS Apr 30, 2024 12:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update AUROPHARMA Revised Stop Loss 1100 from 1064
invest market
INVEST2MARKETS Apr 29, 2024 5:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Delivery Buy AUROPHARMA Above 1140 Stop Loss 1064 Targets 1235-1310
invest market
INVEST2MARKETS Mar 21, 2024 2:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update AUROPHARMA Revised Stop Loss 1000 from 980
Chandrabalan Kochaman
Chandrabalan Kochaman Mar 04, 2024 12:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
soon will reach 1350
Chandrabalan Kochaman
Chandrabalan Kochaman Jul 21, 2023 3:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will reach 950 in the next 3 months
jenti jokham
jenti jokham Jun 30, 2023 12:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
800 if you want
Umesh Dubey
Umesh Dubey May 31, 2023 2:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
598
Milan Shekhat
Milan Shekhat Mar 05, 2023 11:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy Aurobindo pharma target 550 shortly target....
invest market
INVEST2MARKETS Jan 06, 2023 1:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Delivery : Buy Auropharma Above 448 Stop Loss 428 Targets 470-480
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email